# Dalbavancin

NDC: 71839-144
Generic name: dalbavancin
Labeler / Manufacturer: BE Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20260612

FDA application: ANDA219604

## Active ingredients

- DALBAVANCIN HYDROCHLORIDE: 500 mg/25mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71839-144"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71839-144
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c188995-ab05-45c3-a3af-5b1bcd655fdc